This HTML5 document contains 106 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://dx.doi.org/10.1002/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q74428457
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel artículu científicu espublizáu n'abril de 1998 наукова стаття, опублікована у квітні 1998 im April 1998 veröffentlichter wissenschaftlicher Artikel scientific article published on 01 April 1998
p:P577
wds:Q74428457-6F081D83-A720-4511-B081-693375028F74
wdt:P577
1998-04-01T00:00:00Z
p:P407
wds:Q74428457-1E093EB1-41A0-4A33-8000-6239AB8D51B9
wdt:P407
wd:Q1860
p:P2860
wds:Q74428457-FC8532E5-3960-4B33-8653-B5A56B26E97B wds:Q74428457-DA644234-4C03-40E5-B03C-2FE6B431EC5E wds:Q74428457-9825C145-E6FE-4929-B60C-B3A7290365DB wds:Q74428457-9D324013-6AC5-48A2-8AB1-F0644558AA1A wds:Q74428457-9EA4F71B-13E9-4A01-AFC7-960EAFFD4BFA wds:Q74428457-87F570FD-E2F5-4762-B6AE-E5A2E3B6B4B2 wds:Q74428457-8AF14134-9ADB-46B4-A90B-692D21FAC31A wds:Q74428457-8B408585-B256-4DDB-B268-B95E62E91714 wds:Q74428457-BC712C75-58DD-4BD2-9EF7-474A02B2FE7D wds:Q74428457-C4230833-02A3-4170-9BD7-91F16B1677C0 wds:Q74428457-CB1B6C46-8F4D-41C1-BB75-E40FA529FE77 wds:Q74428457-CF4FA0D9-8A79-498B-9056-F590955D8157 wds:Q74428457-A15EEEA2-15BF-4E68-988F-625C0D7936AE wds:Q74428457-A2F3C170-3566-4790-8A42-0DDA6648C70F wds:Q74428457-AC157FFB-B314-475C-9529-82C1AD763245 wds:Q74428457-63168562-5538-47B9-BE50-DCC4C9E5C4DD wds:Q74428457-64295ADA-988E-4374-A97F-05286888AAFE wds:Q74428457-3FBEA257-4B57-44B6-980C-968A38E3387D wds:Q74428457-469CD53D-FDD8-4B28-88DE-1CBF8103B3C8 wds:Q74428457-4EC84086-851C-4FE2-AFCC-662F7848091C wds:Q74428457-5259E277-3712-426C-9218-BBD94476F880 wds:Q74428457-6E87B69E-4940-41F4-92F2-5210C4FE7A0F wds:Q74428457-7F5E146F-5740-4F84-85B5-370630F6D09C wds:Q74428457-684E23ED-589C-46A7-9965-3B11AD607F89 wds:Q74428457-6CE553ED-0909-4730-9DD9-00F1A8883ADB wds:Q74428457-236A5C5C-5F75-4DE8-971C-78F4C153BE63 wds:Q74428457-281742E5-441D-497D-B3A4-CE8E736380E9 wds:Q74428457-2881B943-213B-41BE-8E12-9EDD09C16A3C wds:Q74428457-1B330AEA-D1C8-4B98-A631-86F7B88E6D75 wds:Q74428457-22457ECD-7F1E-49E6-A839-51ECC77CA7D4
wdt:P2860
wd:Q43041709 wd:Q58803541 wd:Q71668750 wd:Q43039883 wd:Q43036080 wd:Q44746801 wd:Q72670203 wd:Q40957762 wd:Q70955349 wd:Q67983807 wd:Q68061408 wd:Q46470418 wd:Q43037990 wd:Q43048305 wd:Q42008293 wd:Q42977051 wd:Q43041019 wd:Q29619627 wd:Q43040784 wd:Q53460454 wd:Q44765507 wd:Q71650797 wd:Q43035819 wd:Q41839327 wd:Q42987918 wd:Q41937839 wd:Q72812587 wd:Q50588728 wd:Q41452526 wd:Q43041718
p:P2093
wds:Q74428457-9E7BB425-5141-4947-9B80-B5AE9DA1CA88 wds:Q74428457-642B6D86-56CB-4569-BF79-59D8BB4800D9 wds:Q74428457-660AB405-DF1B-4C38-9499-D30A9EEC4016
wdt:P2093
R D Goldin B R Bacon G C Farrell
rdfs:label
Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group
skos:prefLabel
Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group
schema:name
Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group
p:P1476
wds:Q74428457-692DE4A1-ECAF-4618-8DFB-C6F41860BB33
wdt:P1476
Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study
p:P304
wds:Q74428457-DCE99108-8F46-4016-A219-2CDE0A2A4BA5
wdt:P304
1121-1127
p:P31
wds:Q74428457-E8B048D2-C622-4D55-9D83-A11EF41D4ED7
wdt:P31
wd:Q13442814
p:P921
wds:Q74428457-81FB77A9-B18B-4BB6-9730-FD0CDF5805F0 wds:Q74428457-53166316-6DA9-4304-8472-EB63447F98BC wds:Q74428457-0518B295-0CA4-4658-B001-4394A82D59E9
wdt:P921
wd:Q154869 wd:Q55779873 wd:Q62019625
p:P698
wds:Q74428457-B4406C97-5EFF-49EF-B7BA-941C4B5C7D03
wdtn:P698
n11:9537453
wdt:P698
9537453
p:P1433
wds:Q74428457-D30D6480-341B-4FC2-929F-E9799AE2DA32
wdt:P1433
wd:Q15724398
p:P433
wds:Q74428457-39AD1933-E8AB-4030-A4F2-126A3F5A246B
p:P478
wds:Q74428457-8A2A9EEF-7064-4B96-A9DB-2F2AD4D0BA59
wdt:P433
4
wdt:P478
27
p:P356
wds:Q74428457-174E937E-D52E-44C3-AB7F-CDBDDFECD8FC
wdtn:P356
n12:HEP.510270429
wdt:P356
10.1002/HEP.510270429